The Lost Microbe?

The “Lost Microbe” L. reuteri: What Science Says About the 96% Claim and Reported Benefits

An estimated 96% of people in modern industrialized societies no longer carry detectable levels of Limosilactobacillus reuteri (formerly Lactobacillus reuteri), a bacterium once common in the human gut. Proponents, including Dr. Eric Berg (a chiropractor, not an MD), link its disappearance—driven by antibiotics, highly processed diets, sanitation, and reduced breastfeeding—to higher rates of anxiety, depression, poorer sleep, accelerated physical aging, and related issues. Restoring it, they say, has been associated with increased muscle mass, thicker hair, younger-looking skin, improved libido, lower cortisol, and better mood.

The core observation about declining prevalence is real. Multiple lines of evidence show L. reuteri is now rare in Western populations (often estimated around 4–10% or lower with detectable levels in fecal samples) while remaining more common in some non-industrialized groups and historically more frequent in mid-20th-century samples. Comparative microbiome work has highlighted L. reuteri as one of the species largely absent from modern Western guts. See the foundational review Host-microbial symbiosis and the Lactobacillus reuteri paradigm (Walter et al., PNAS 2011) and later work confirming its presence in rural Papua New Guineans but near-absence in U.S. controls, such as the gut microbiota of rural Papua New Guineans (Cell Reports 2015). A 2025 Cell trial testing reintroduction also found it rare at baseline in a Western cohort and difficult to establish long-term.

Antibiotics are particularly disruptive to lactobacilli, and broader lifestyle shifts contribute to overall microbiome depletion.

Mechanisms and Strain Specificity

L. reuteri produces antimicrobial compounds such as reuterin and can modulate immune signaling. Research from groups at MIT and others has linked certain strains (notably ATCC PTA 6475) to increased oxytocin signaling in mice, with downstream effects on wound healing, social behavior, skin thickness, and other markers. Key papers include the original mouse work Microbial Symbionts Accelerate Wound Healing via the Neuropeptide Hormone Oxytocin (PLoS ONE 2013) and the human pilot plus lysate findings in Microbial lysate upregulates host oxytocin (Brain, Behavior, and Immunity 2017).

Effects are highly strain-specific. The best-studied strains include:

• DSM 17938 (widely available, often as BioGaia Protectis): strongest evidence for gastrointestinal benefits, especially infantile colic and certain diarrheas.
• ATCC PTA 6475: more tied to the oxytocin/immune/skin/bone research threads.
• Combinations of the two (e.g., BioGaia Gastrus) used in some IBS and other studies.

Colonization is typically transient; counts usually drop within days to a couple of weeks after stopping supplementation unless the gut environment supports persistence. A solid overview of the evidence base is available at Examine.com’s Lactobacillus reuteri research breakdown.

Evidence Levels for the Popular Claims

Stronger human evidence exists for certain GI effects (colic, antibiotic-associated or infectious diarrhea, some IBS symptom relief in trials using specific strains or combinations). Immune modulation appears in multiple studies.

Promising but preliminary or mixed areas include:

• Wound healing (small human pilot supporting mouse findings, linked above).
• Bone density: a smaller trial in older women with low bone mineral density showed reduced loss with ATCC PTA 6475 (Nilsson et al., Journal of Internal Medicine 2018); a larger, longer trial in early postmenopausal women found no overall benefit (JAMA Network Open 2024).
• Mood, sleep, skin appearance, hair, libido, and body composition: primarily mouse data or self-reported anecdotes from people making high-CFU “L. reuteri yogurt” (often via extended 36-hour fermentation of BioGaia tablets with prebiotic fiber). Community reports are frequent but uncontrolled. Direct human RCTs for these aesthetic or hormonal endpoints remain limited or absent.

Mouse studies produced dramatic results on aging-related markers and oxytocin that have fueled online interest. Translating those to humans has been inconsistent so far, particularly for hormonal and aesthetic claims. High-dose homemade yogurt may deliver substantially more CFUs than standard supplements, which could explain some anecdotal differences, but this has not been rigorously tested head-to-head in large trials.

Practical Context

Standard commercial supplements (often 10⁸–10¹⁰ CFU range) are well-tolerated in studies and easiest for consistent dosing. The popular DIY yogurt approach aims for much higher counts through prolonged fermentation and is widely discussed in functional-health circles, though quality control and exact yields vary. Persistence usually requires ongoing intake.

L. reuteri is generally regarded as safe for healthy people, but individuals who are immunocompromised, critically ill, or have certain GI conditions should consult a clinician before use. It is not a proven treatment for anxiety, depression, aging, or the other conditions listed in the original claim.

Bottom Line

The decline of L. reuteri in Western microbiomes is a documented phenomenon consistent with broader patterns of microbiome change. It has legitimate, strain-specific benefits for gut comfort and some immune effects, plus intriguing mechanistic links to oxytocin and tissue repair. Claims of widespread “youthful” restoration of muscle, hair, skin, libido, and mood currently rest more on animal data, small pilots, and enthusiastic anecdotes than on large, confirmatory human trials. Restoring missing microbes is an active research area, but results are not automatic or universal.

This remains an evolving field. Anyone considering supplementation should look at specific strains, existing evidence for their goals, and discuss it with a healthcare provider—especially if they have medical conditions or take medications.

Information only; not medical advice. Dr. Eric Berg, DC, not MD.